Resources

Myricx Bio announces that it has been awarded the Cancer Research Horizons Start-Up Achievement Recognition Award for 2025, which it received at a ceremony in London last night.

Responding to the Life Sciences Sector Plan, BIA Chair Dr Daniel Mahony said the following.

Coulter Partners successfully completed a search assignment for QBiotics Group Limited (QBiotics) and announces the placement of Sergio Duchini as Non-executive Director.

PIR International spoke with the Chief Executive Officer of Muna Therapeutics, Rita Balice-Gordon, as part of their BioLeader interview series.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has announced the winners of its third Innovation and Entrepreneurship Awards.

In this article, Kate Barclay, Skills Strategy Consultant at BIA, outlines new changes to UK immigration law and how they will impact the life sciences sector. Prepared in collaboration with legal experts at Eversheds-Sutherland LLP.

Coulter Partners successfully completed a search assignment for Biomia and is pleased to announce the placement of Frederick Westhorpe, PhD as Chief Scientific Officer (CSO).

NHS 10 Year Health Plan for England, a strategy for European Life Sciences and hope to see you at the “sunny” BIA Summer Party on Wednesday.

Coulter Partners successfully completed search assignments for Augustine Therapeutics NV.

Cancer Research Horizons, the innovation arm of Cancer Research UK, has appointed its first Clinical Advisory Board to provide strategic guidance on the development of novel cancer therapeutics emerging from its drug discovery division, Therapeutic Innovation.

Discovery Park opened its doors for the East Kent Science Jamboree, hosting a record-breaking 1,500 children from 51 Kent schools for a two-day science spectacular.

Aravax announced the appointment of Dr Adrian Parry as Director of CMC (Chemistry, Manufacturing and Controls), based at the Company’s Oxford, UK site.

Present Made, Eddington, is leading the way with Cambridge’s first purpose-built, large-scale corporate letting scheme – a pioneering development that brings 21st-century executive living to one of the UK’s most dynamic science and technology hubs.

In this Q&A blog, BIA spoke to Natasha Gray, Associate & Life Sciences Advisory Service Lead at Warn, a new BIA member.

UK life sciences take centre stage at BIO following a promising Spending Review.

A new residential development in North Cambridge is offering science and technology businesses a ready-made solution to one of the city’s most pressing challenges: housing professional staff within easy reach of major employment hubs.

From a multi-billion-pound boost to R&D and life sciences manufacturing, to scaling innovative businesses through the British Business Bank, the Review signals significant investment.

Steve Bates OBE, CEO of the UK BioIndustry Association, responded to the government's Spending Review.

Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that Dr Robert Tansley is appointed Chief Medical Officer with immediate effect.